Conformationally restricted analogues of both (S)-β-homoserine and (S)-aspartic acid from chiral 3-acylamino pyrrolidin-2-ones

Tetrahedron

Volumn 61, Issue 23, 2005, Pages 5465-5473

  Galeazzi, Roberta ^a   Martelli, Gianluca ^a   Orena, Mario ^a   Rinaldi, Samuele ^a   Sabatino, Piera ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Amino acids; Analogues; Baylis Hillman; Conformational constrictions; Peptidomimetics

Indexed keywords

3 ACYLAMINOPYRROLIDIN 2 ONE; ASPARTIC ACID; HOMOSERINE; UNCLASSIFIED DRUG;

ARTICLE; BAYLIS HILLMAN REACTION; CHIRALITY; CONFORMATION; ENANTIOMER; PRIORITY JOURNAL; STRUCTURE ANALYSIS; SUBSTITUTION REACTION; SYNTHESIS;

EID: 19044390133     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2005.03.129     Document Type: Article

References (69)

1. For reviews on this topic, see: (a) A. Giannis, and T. Kolter Angew. Chem., Int. Ed. Engl. 32 1993 1244 1267
2. J. Gante Angew. Chem., Int. Ed. Engl. 33 1994 1699 1720
3. S. Hanessian, G. McNaughton-Smith, H.-G. Lombart, and W.D. Lubell Tetrahedron 53 1997 12789 12854
4. P. Gillespie, J. Cicariello, and G.L. Olson Biopolym. (Peptide Sci.) 43 1997 191 217
5. M. Goodman A. Felix L. Moroder C. Toniolo Synthesis of peptides and peptidomimetics Houben-Weyl, methods in organic chemistry Vol. E22c 2003 Thieme Stuttgart, NY
6. R.M. Freidinger, D.F. Veber, D.S. Perlow, J.R. Brooks, and R. Saperstein Science 210 1980 656 658
7. R.M. Freidinger, D.S. Perlow, and D.F. Veber J. Org. Chem. 47 1982 104 109
8. R.M. Freidinger J. Org. Chem. 50 1985 3631 3633
9. G. Valle, M. Crisma, C. Toniolo, K.-L. Yu, and R.L. Johnson J. Chem. Soc., Perkin Trans. 2 1989 83 87
10. J. Aubé Synthetic routes to lactam peptidomimetics Advances in amino acid mimetics and peptidomimetics Vol. 1 1997 JAI Greenwich, CT pp 193-232
11. R.M. Freidinger J. Med. Chem. 46 2003 5553 5566
12. K. Dolbeare, G.F. Pontoriero, S.K. Gupta, R.K. Mishra, and R.L. Johnson J. Med. Chem. 46 2003 727 733
13. M.W. Holladay, and A.M. Nadzan J. Org. Chem. 56 1991 3900 3905
14. K.M.K Swamy, M.-J. Lin, and C.-M. Sun Mini Rev. Med. Chem. 3 2003 621 631
15. M.P. Glenn, and D.P. Fairliue Mini Rev. Med. Chem. 2 2002 433 445
16. K.K. Suat, and S.D.S. Jois Curr. Pharm. Des. 9 2003 1209 1224
17. B. Cardillo, R. Galeazzi, G. Mobbili, and M. Orena Synlett 1995 1159 1160
18. R. Galeazzi, G. Mobbili, and M. Orena Tetrahedron 52 1996 1069 1084
19. R. Galeazzi, S. Geremia, G. Mobbili, and M. Orena Tetrahedron: Asymmetry 7 1996 79 88
20. R. Galeazzi, S. Geremia, G. Mobbili, and M. Orena Tetrahedron: Asymmetry 7 1996 3573 3584
21. R. Galeazzi, G. Mobbili, and M. Orena Tetrahedron: Asymmetry 8 1997 133 137
22. R. Galeazzi, G. Mobbili, and M. Orena Tetrahedron 55 1999 261 270
23. R. Galeazzi, G. Mobbili, and M. Orena Tetrahedron 55 1999 4029 4042
24. C. Fava, R. Galeazzi, G. Mobbili, and M. Orena Tetrahedron: Asymmetry 14 2003 3697 3703
25. R. Galeazzi, G. Martelli, G. Mobbili, M. Orena, and S. Rinaldi Tetrahedron: Asymmetry 14 2003 3353 3358
26. R. Galeazzi, G. Martelli, G. Mobbili, M. Orena, and M. Panagiotaki Heterocycles 60 2003 2485 2498
27. R. Galeazzi, G. Martelli, G. Mobbili, M. Orena, and S. Rinaldi Tetrahedron: Asymmetry 15 2004 3249 3256
28. M. Ciclosi, C. Fava, R. Galeazzi, M. Orena, and J. Sepulveda-Arques Tetrahedron Lett. 43 2002 2199 2202
29. O.C. Billeter Ber. 1903 3213 3221
30. A.J. Hill, and W.M. Degnan J. Am. Chem. Soc. 62 1940 1595 1596
31. L.E. Overman J. Am. Chem. Soc. 96 1974 597 599
32. L.E. Overman J. Am. Chem. Soc. 98 1976 2901 2910
33. M. Mehmandust, Y. Petit, and M. Larcheveque Tetrahedron Lett. 33 1992 4313 4316
34. C. Martin, M. Bortolussi, and R. Bloch Tetrahedron Lett. 40 1999 3735 3736
35. T. Nishikawa, M. Asai, N. Ohyabu, and M. Isobe J. Org. Chem. 63 1998 188 192
36. S.H. Kang, G.T. Kim, and Y.S. Yoo Tetrahedron Lett. 38 1997 603 606
37. S.H. Kang, J.S. Kim, and J.-H. Youn Tetrahedron Lett. 39 1998 9047 9050
38. R. Galeazzi, G. Martelli, M. Orena, and S. Rinaldi Synthesis 2004 2560 2566
39. 1H NMR spectra the signals corresponding to each isomer could be identified. In contrast, treatment of the diastereomeric mixture of 3-tosylamino derivatives with DBU led exclusively to the corresponding α,β- unsaturated pyrrolidin-2-one in a quantitative yield, via elimination of tosylamide.
40. Sheldrick, G. M. SHELXS97, University of Gottingen, Germany, 1997.
41. Sheldrick, G. M. SHELXL97, University of Gottingen, Germany, 1997.
42. For syntheses of constrained analogues of β-homoserine see: (a) A. Avenoza, C. Cativiela, M.A. Fernández-Recio, and J.M. Peregrina Tetrahedron: Asymmetry 7 1996 721 728
43. K. Hammer, C. Rømming, and K. Undheim Tetrahedron 54 1998 10837 10850
44. K. Hammer, and K. Undheim Tetrahedron: Asymmetry 9 1998 2359 2368
45. S. Krikstolaityte, A. Sackus, C. Rømming, and K. Undheim Tetrahedron: Asymmetry 12 2001 393 398
46. For biological activity of β-homoserine, see: (a) F. Barclay, E. Chrystal, and D. Gani J. Chem. Soc., Chem. Commun. 1994 815 816
47. F. Barclay, E. Chrystal, and D. Gani J. Chem. Soc., Perkin Trans. 1 1996 683 690
48. For biological activity of the derivatives of β-homoserine, see: (a) G. Telford, D. Wheeler, P. Williams, P.T. Tomkins, P. Appleby, H. Sewell, G.S.A.B. Stewart, B.W. Bycroft, and D.I. Pritchard Infect. Immun. 66 1998 36 42
49. R.N. Lawrence, W.R. Dunn, B.W. Bycroft, M. Camara, S.R. Chhabra, P. Williams, and V.G. Wilson Br. J. Pharmacol. 128 1999 845 848
50. S.R. Chhabra, C. Harty, D.S.W. Hooi, M. Daykin, P. Williams, G. Telford, D.I. Pritchard, and B.W. Bycroft J. Med. Chem. 46 2003 97 104
51. J.A. Olsen, R. Severinsen, T.B. Rasmussen, M. Hentzer, M. Givskov, and J. Nielsen Bioorg. Med. Chem. Lett. 12 2002 325 328
52. S. Reverchon, B. Chantegrel, C. Deshayes, A. Doutheau, and N. Cotte-Pattat Bioorg. Med. Chem. Lett. 12 2002 1153 1157
53. S. Castang, B. Chantegrel, D. Christian, R. Dolmazon, P. Gouet, R. Haser, S. Reverchon, W. Nasser, N. Hugouvieux-Cotte-Pattat, and A. Doutheau Bioorg. Med. Chem. Lett. 14 2004 5145 5149
54. K.M. Kaiser Synthesis 1972 391 415
55. A.W. Burgstahler, L.R. Worden, and T.B. Lewis J. Org. Chem. 28 1963 2918 2919
56. H.V. Pinnick, and E. Fernandez J. Org. Chem. 44 1979 2810 2812
57. H. Ohkura, M. Handa, T. Katagiri, and K. Uneyama J. Org. Chem. 67 2002 2692 2695
58. For recent reviews about isosteres and constrained analogues of aspartic acid, see: (a) A.R. Chamberlin, H.P. Koch, and R.J. Bridges Methods Enzymol. 296 1998 175 189
59. P. Stefanic, and M.S. Dolenc Curr. Med. Chem. 11 2004 945 968
60. For reviews, see: (a) D.J. Hill, M.J. Mio, R.B. Prince, T.S. Hughes, and J.S. Moore Chem. Rev. 101 2001 3893 4012
61. R.P. Cheng Curr. Opin. Struct. Biol. 14 2004 512 520
62. For recent examples of β-foldamers see: (a) J.D. Fisk, D.R. Powell, and S.H. Gellman J. Am. Chem. Soc. 122 2000 5443 5447
63. D. Seebach, J.V. Schreiber, S. Abele, X. Daura, and W.F. van Gunsteren Helv. Chim. Acta 83 2000 34 57
64. P.I. Arvidsson, M. Rueping, and D. Seebach Chem. Commun. 2001 649 650
65. E.A. Porter, B. Weisblum, and S.H. Gellman J. Am. Chem. Soc. 124 2002 7324 7330
66. R. Baron, D. Bakowies, W.F. van Gunsteren, and X. Daura Helv. Chim. Acta 85 2002 3872 3882
67. B.R. Huck, J.D. Fisk, I.A. Guzei, H.A. Carlson, and S.H. Gellman J. Am. Chem. Soc. 125 2003 9035 9037
68. J.M. Brown, M. Rose, F.I. Knight, and A. Wienand Recl. Trav. Chim. Pays-Bas 114 1995 242 252
69. A. Bongini, G. Cardillo, M. Orena, and S. Sandri Synthesis 1979 2545 2546